Mark Pesce on Nostr: Gilead Shot Prevents All HIV Cases in Trial of African Women Gilead Sciences Inc.’s ...
Gilead Shot Prevents All HIV Cases in Trial of African Women
Gilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in women and adolescent girls in Africa, the first successful big trial of what’s hoped to become a powerful new drug regimen for fending off the virus.
Lenacapavir will provide an easier-to-use option compared to other HIV prevention drugs that are either daily pills or must be injected every two months. https://www.msn.com/en-us/health/other/gilead-shot-prevents-all-hiv-cases-in-trial-of-african-women/ar-BB1oAfz8
Gilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in women and adolescent girls in Africa, the first successful big trial of what’s hoped to become a powerful new drug regimen for fending off the virus.
Lenacapavir will provide an easier-to-use option compared to other HIV prevention drugs that are either daily pills or must be injected every two months. https://www.msn.com/en-us/health/other/gilead-shot-prevents-all-hiv-cases-in-trial-of-african-women/ar-BB1oAfz8